Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Patients taking tirzepatide may show: Improved glycemic markers : Lower fasting glucose and reduced hemoglobin A1c levels Potential lipid profile changes : Possible decreases in triglycerides and changes in cholesterol parameters Liver function parameters : Possible changes in liver enzymes in patients with fatty liver disease Kidney function monitoring : Serum creatinine and estimated glomerular filtration rate should be tracked, particularly if dehydration occurs It is important to note that tirzepatide has no known interference with standard laboratory assays and is not included in standard drug screening tests, which typically focus on substances of abuse and controlled medications
25 In the light of the current focus on cardiovascular safety of weight-loss drugs, 28, 29 the favorable effect on cardiovascular risk factors in the current trial seems promising
Furthermore, the most effective GLP-1 medications can help patients achieve over 20% weight reduction
Proper storage of Wegovy is essential
